Opelconazole

N/A

Report date: 2026/01/16 20:01:23
NME

Base Information

Drug NameOpelconazole
Drug Alias NamePC-945
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsRejection of lung transplantationPulmonary Disease, Chronic ObstructiveBronchiectasis +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[20] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPulmocide Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPulmocide Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Aspergillosis
Inactive IndicationsRejection of lung transplantationPulmonary Disease, Chronic ObstructiveBronchiectasis +[6] 

Other Information

ATC CodeN/A
Related LinksN/A